Chemplast Sanmar

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE488A01050
  • NSEID: CHEMPLASTS
  • BSEID: 543336
INR
195.67
-5.96 (-2.96%)
BSENSE

Jul 21, 03:30 PM

BSE+NSE Vol: 3.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.58 lacs (15.47%) Volume

Shareholding (Jun 2026)

FII

12.02%

Held by 48 FIIs

DII

23.71%

Held by 30 DIIs

Promoter

54.99%

Why is Chemplast Sanmar Ltd falling/rising?

21-Jul-2026

As of 20-Jul, Chemplast Sanmar Ltd's stock price is rising to Rs 202.85, reflecting a 3.68% increase due to positive market sentiment and increased investor participation. However, the stock has faced significant long-term challenges, including a year-to-date decline of 22.58% and a high debt-to-EBITDA ratio, indicating financial risks.

As of 20-Jul, Chemplast Sanmar Ltd's stock price is rising, currently at Rs 202.85, reflecting a change of Rs 7.2 or 3.68% increase. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 2.26% today, indicating positive market sentiment. Additionally, it reached an intraday high of Rs 205.2, which is a 4.88% increase from the previous price.<BR><BR>Investor participation has also increased, as evidenced by a rise in delivery volume by 4.7% against the 5-day average, suggesting growing interest among investors. Furthermore, the company demonstrates high management efficiency with a return on capital employed (ROCE) of 19.61%, and it has reported its highest net sales at Rs 1,255.55 crore and operating profit before depreciation, interest, and tax (PBDIT) at Rs 194.34 crore.<BR><BR>However, it is important to note that despite the current rise, the stock has faced significant challenges over the longer term, including a year-to-date decline of 22.58% and a staggering 55.38% drop over the past year. The company also has a high debt-to-EBITDA ratio of 9.86 times, indicating a low ability to service its debt, which poses risks to its financial stability. Despite these concerns, the recent performance indicates a temporary rise in stock price, driven by increased investor interest and positive operational metrics.

View full answer

Which are the latest news on Chemplast Sanmar?

21-Jul-2026

What does Chemplast Sanmar do?

11-Jun-2026

Chemplast Sanmar Ltd is a small-cap company in the commodity chemicals industry, incorporated in 1985, with recent quarterly net sales of ₹1,256 Cr and a net profit of -₹45 Cr as of March 2026. The company has a market cap of ₹3,267 Cr and operates from Chennai, Tamil Nadu.

Overview: <BR>Chemplast Sanmar Ltd operates in the commodity chemicals industry and is categorized as a small-cap company.<BR><BR>History: <BR>Incorporated in 1985, Chemplast Sanmar Limited was initially promoted as 'Urethanes India' and became a fully-owned subsidiary of Chemplast in 1991. The company changed its name from Chemicals & Plastics India Limited to Chemplast Sanmar Limited on September 28, 1995. The latest quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 1,256 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: -45 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 3,267 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.76 <BR>Return on Equity: -7.41% <BR>Price to Book: 1.78<BR><BR>Contact Details: <BR>Address: 9 Cathedral Road, Chennai Tamil Nadu: 600086 <BR>Tel: +91-44-28128500 <BR>Email: grd@sanmargroup.com <BR>Website: http://www.chemplastsanmar.com

View full answer

How big is Chemplast Sanmar?

11-Jun-2026

As of 10th June, Chemplast Sanmar Ltd has a market capitalization of 3,267.00 Cr and reported Net Sales of 4,223.79 Cr, with a Net Profit loss of 279.87 Cr over the latest 4 quarters. Shareholder's Funds are 2,068.43 Cr and Total Assets are 6,503.19 Cr.

As of 10th June, Chemplast Sanmar Ltd has a market capitalization of 3,267.00 Cr, classifying it as a Small Cap company.<BR><BR>In the latest 4 quarters, Chemplast Sanmar reported Net Sales of 4,223.79 Cr. However, the company experienced a loss of 279.87 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period for the balance sheet is March 2025. Shareholder's Funds amounted to 2,068.43 Cr, while Total Assets were reported at 6,503.19 Cr.

View full answer

Who are in the management team of Chemplast Sanmar?

11-Jun-2026

The management team of Chemplast Sanmar includes Vijay Sankar (Chairman), Ramkumar Shankar (Managing Director), and several independent and non-executive directors, including Lakshmi Vijayakumar, Aditya Jain, and Sanjay Bhandarkar, among others. M Raman serves as the Company Secretary & Compliance Officer.

The management team of Chemplast Sanmar includes the following individuals:<BR><BR>1. **Vijay Sankar** - Chairman (Non-Executive)<BR>2. **Ramkumar Shankar** - Managing Director<BR>3. **Chandran Ratnaswami** - Non-Executive & Non-Independent Director<BR>4. **Lakshmi Vijayakumar** - Independent Director<BR>5. **Aditya Jain** - Independent Director<BR>6. **Sanjay Bhandarkar** - Independent Director<BR>7. **Prasad R Menon** - Independent Director<BR>8. **M Raman** - Company Secretary & Compliance Officer<BR>9. **Vikram Taranath Hosangady** - Non-Executive Director<BR><BR>If you have any more questions about Chemplast Sanmar or its operations, feel free to ask!

View full answer

Who are the peers of the Chemplast Sanmar?

11-Jun-2026

Chemplast Sanmar's peers include Gujarat Alkalies, GHCL, Tanfac Inds., and others, with varying management risks and growth ratings. Chemplast Sanmar has the lowest 1-year return at -54.49%, significantly underperforming its peers.

Peers: The peers of Chemplast Sanmar are Gujarat Alkalies, GHCL, Tanfac Inds., Grauer & Weil, Fischer Medical, Thirumalai Chem., J.G.Chemicals, I G Petrochems, and TGV Sraac.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Tanfac Inds., while Average management risk is found at Gujarat Alkalies, Grauer & Weil, Thirumalai Chem., J.G.Chemicals, I G Petrochems, and TGV Sraac, and Below Average at Fischer Medical. Growth is rated as Excellent for Fischer Medical, Good for Tanfac Inds. and J.G.Chemicals, and Below Average for Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, Thirumalai Chem., I G Petrochems, and TGV Sraac. Capital Structure is rated as Excellent for Gujarat Alkalies, GHCL, Tanfac Inds., J.G.Chemicals, and I G Petrochems, Below Average for Chemplast Sanmar and Thirumalai Chem., and Good for Fischer Medical and TGV Sraac.<BR><BR>Return Snapshot: The peer with the highest 1-year return is J.G.Chemicals at 10.19%, while the lowest is Chemplast Sanmar at -54.49%, indicating that Chemplast Sanmar's return is significantly worse than its peers. Additionally, peers such as GHCL, Fischer Medical, Thirumalai Chem., and Chemplast Sanmar have negative six-month returns.

View full answer

Should I buy, sell or hold Chemplast Sanmar Ltd?

28-May-2026

Are Chemplast Sanmar Ltd latest results good or bad?

26-May-2026

Chemplast Sanmar Ltd's latest results are mixed; while net sales increased by 50.34% and operating margins improved, the company reported a net loss of ₹45.38 crores for the sixteenth consecutive quarter, raising concerns about its ongoing financial distress and high debt levels.

Chemplast Sanmar Ltd's latest results present a mixed picture. In the fourth quarter of FY26, the company reported a net loss of ₹45.38 crores, which, while an improvement of 61.93% from the previous quarter's loss, still reflects ongoing financial distress as it marks the sixteenth consecutive quarter of negative earnings. <BR><BR>On the positive side, the company achieved a significant revenue increase, with net sales rising by 50.34% quarter-on-quarter to ₹1,255.55 crores, driven by better realizations and volume growth in its specialty chemicals segment. Additionally, the operating margin improved to 15.48%, the highest in eight quarters, indicating operational efficiency.<BR><BR>However, despite these operational improvements, the inability to convert revenue growth into profitability raises concerns. The company's high debt burden and persistent losses suggest structural issues that may hinder its recovery. The overall sentiment among investors appears cautious, as reflected in the stock's significant decline over the past year.<BR><BR>In summary, while Chemplast Sanmar has shown operational improvements, the continued net losses and high debt levels indicate that the results are more concerning than positive.

View full answer

When is the next results date for Chemplast Sanmar Ltd?

20-May-2026

The next results date for Chemplast Sanmar Ltd is 25 May 2026.

The next results date for Chemplast Sanmar Ltd is scheduled for 25 May 2026.

View full answer

Is Chemplast Sanmar technically bullish or bearish?

03-Dec-2025

As of December 2, 2025, Chemplast Sanmar's technical trend has shifted to a bearish stance with moderate strength, supported by bearish indicators across multiple timeframes, despite some mildly bullish signals in the monthly analysis.

As of 2 December 2025, the technical trend for Chemplast Sanmar has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands and KST on both weekly and monthly timeframes, and bearish moving averages on the daily chart. The Dow Theory also confirms a bearish trend across both weekly and monthly perspectives. Despite a mildly bullish monthly MACD and bullish monthly RSI, the overall technical picture remains negative, particularly in the short term.

View full answer

How has been the historical performance of Chemplast Sanmar?

01-Dec-2025

Chemplast Sanmar's historical performance shows a decline in net sales and profits from a peak in March 2022, with net sales dropping from 5,891.99 Cr to 4,346.07 Cr by March 2025, and profit after tax turning negative at -110.36 Cr. Despite an increase in total assets and liabilities, the company has faced significant challenges in profitability and cash flow in recent years.

Answer:<BR>The historical performance of Chemplast Sanmar shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemplast Sanmar's net sales peaked at 5,891.99 Cr in March 2022 but have since declined to 4,346.07 Cr in March 2025. The total operating income followed a similar pattern, reaching a high of 5,891.99 Cr in March 2022 before dropping to 4,346.07 Cr in March 2025. The company experienced significant variations in operating profit, with a high of 1,254.29 Cr in March 2022, but a decline to 265.72 Cr by March 2025. Profit before tax turned negative in March 2024 and 2025, with figures of -225.57 Cr and -169.07 Cr, respectively, after being positive in earlier years. The profit after tax also reflected this downturn, moving from a high of 648.65 Cr in March 2022 to -110.36 Cr in March 2025. Total liabilities increased from 4,107.54 Cr in March 2020 to 6,503.19 Cr in March 2025, while total assets rose from 4,107.54 Cr to 6,503.19 Cr in the same period. Cash flow from operating activities has been negative in the last two years, with -244.00 Cr in March 2024 and a further decline in March 2025. Overall, Chemplast Sanmar's financial performance indicates challenges in profitability and cash flow, despite growth in total assets and liabilities.

View full answer

Who are the top shareholders of the Chemplast Sanmar?

17-Jul-2025

The top shareholders of Chemplast Sanmar are Sanmar Holdings Limited with 54.99%, mutual funds owning 24.11%, and foreign institutional investors holding 13.27%. SBI Long Term Equity Fund is the largest public shareholder at 9.82%, while individual investors hold about 4.57%.

The top shareholders of Chemplast Sanmar include Sanmar Holdings Limited, which holds the largest stake at 54.99%. Other significant shareholders are mutual funds, which collectively own 24.11% through 12 schemes, and foreign institutional investors (FIIs) with a combined holding of 13.27% across 80 FIIs. Additionally, SBI Long Term Equity Fund is the highest public shareholder with 9.82%. Individual investors hold about 4.57% of the company.

View full answer

Is Chemplast Sanmar overvalued or undervalued?

13-Jun-2025

As of June 12, 2025, Chemplast Sanmar is considered overvalued with a PE ratio of -62.46 and an EV to EBITDA of 36.64, underperforming the Sensex with a stock return of -17.71% compared to the Sensex's 6.64%.

As of 12 June 2025, Chemplast Sanmar's valuation grade has moved from fair to expensive. The company is currently overvalued, with a PE ratio of -62.46, an EV to EBITDA ratio of 36.64, and a Price to Book Value of 3.33. These ratios indicate significant concerns regarding profitability and valuation relative to its assets.<BR><BR>In comparison to its peers, Chemplast Sanmar's valuation stands out unfavorably; for instance, Godrej Industries is rated attractive with a PE of 44.06 and an EV to EBITDA of 33.16. Additionally, Solar Industries is categorized as very expensive with a PE of 124.55 and an EV to EBITDA of 76.70. Furthermore, Chemplast Sanmar has underperformed the Sensex over the past year, with a stock return of -17.71% compared to the Sensex's 6.64%, reinforcing the notion that the stock is currently overvalued.

View full answer

Has Chemplast Sanmar declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.86 times

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.86 times
  • The company has been able to generate a Return on Equity (avg) of 9.92% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of -7.98% and Operating profit at -134.63% over the last 5 years

 
3

Risky - Negative Operating Profits

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 3,134 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

47

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.76

stock-summary
Return on Equity

-7.41%

stock-summary
Price to Book

1.84

Revenue and Profits:
Net Sales:
1,256 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-45 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.04%
0%
-21.04%
6 Months
-23.34%
0%
-23.34%
1 Year
-58.14%
0%
-58.14%
2 Years
-61.16%
0%
-61.16%
3 Years
-54.61%
0%
-54.61%
4 Years
-59.31%
0%
-59.31%
5 Years
0%
0%
0.0%

Chemplast Sanmar for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Publish Audited Results

15-May-2012 | Source : NSE


Chemplast Sanmar Limited has informed the Exchange that the Company to publish the audited results for the financial year ended March 31, 2012.

Sale of Shares

11-May-2012 | Source : NSE


Life Insurance Corporation of India has informed the Exchange vide its letter dated May 07, 2012 that: "As per the guideline on Institutional Transactions in shares issued by Govt. of India on February 20, 1990, we hereby inform that Life Insurance Corporation of India has sold 4,06,58,108 equity shares face value of Rs.1/- each of Chemplast Sanmar Ltd. @ Rs.15/- per share".

Post Offer Public Announcement

23-Apr-2012 | Source : NSE


Inga Capital Private Limited has submitted to the Exchange a copy of Post Offer Public issued in the Newspaper on April 23, 2012 with respect to the Voluntary Delisting of equity shares ("Equity Shares") of Chemplast Sanmar Limited ("Company").

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Chemplast Sanmar Ltd has announced 1:10 stock split, ex-date: 08 Mar 06

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Chemplast Sanmar Ltd has announced 2:3 rights issue, ex-date: 17 Mar 09

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-7.98%
EBIT Growth (5y)
-134.63%
EBIT to Interest (avg)
0.95
Debt to EBITDA (avg)
11.36
Net Debt to Equity (avg)
0.76
Sales to Capital Employed (avg)
1.59
Tax Ratio
24.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
35.73%
ROCE (avg)
26.39%
ROE (avg)
9.92%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
47
Price to Book Value
1.76
EV to EBIT
-290.41
EV to EBITDA
22.36
EV to Capital Employed
1.43
EV to Sales
1.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.49%
ROE (Latest)
-7.41%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (23.3%)

FIIs

Held by 48 FIIs (12.02%)

Promoter with highest holding

Sanmar Holdings Limited (54.99%)

Highest Public shareholder

Sbi Small Cap Fund (9.73%)

Individual Investors Holdings

6.82%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 50.34% vs -19.17% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 61.93% vs -133.54% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,255.55",
          "val2": "835.14",
          "chgp": "50.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "194.34",
          "val2": "-56.75",
          "chgp": "442.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.62",
          "val2": "58.24",
          "chgp": "-1.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-149.92",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-45.38",
          "val2": "-119.20",
          "chgp": "61.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.48%",
          "val2": "-6.80%",
          "chgp": "22.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -0.21% vs 7.74% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -1,464.31% vs 80.56% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,133.10",
          "val2": "2,137.64",
          "chgp": "-0.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.32",
          "val2": "149.89",
          "chgp": "-59.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "119.53",
          "val2": "115.44",
          "chgp": "3.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-115.29",
          "val2": "-7.37",
          "chgp": "-1,464.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.83%",
          "val2": "7.01%",
          "chgp": "-4.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -7.10% vs 11.24% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -317.32% vs 55.86% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,968.24",
          "val2": "3,195.19",
          "chgp": "-7.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.57",
          "val2": "181.94",
          "chgp": "-98.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "177.77",
          "val2": "174.22",
          "chgp": "2.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-234.49",
          "val2": "-56.19",
          "chgp": "-317.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.12%",
          "val2": "5.69%",
          "chgp": "-5.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -2.81% vs 10.78% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -153.60% vs 30.34% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,223.79",
          "val2": "4,346.07",
          "chgp": "-2.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "197.91",
          "val2": "218.67",
          "chgp": "-9.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "235.39",
          "val2": "235.88",
          "chgp": "-0.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-149.92",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-279.87",
          "val2": "-110.36",
          "chgp": "-153.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.69%",
          "val2": "5.03%",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
1,255.55
835.14
50.34%
Operating Profit (PBDIT) excl Other Income
194.34
-56.75
442.45%
Interest
57.62
58.24
-1.06%
Exceptional Items
-149.92
0.00
Consolidate Net Profit
-45.38
-119.20
61.93%
Operating Profit Margin (Excl OI)
15.48%
-6.80%
22.28%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 50.34% vs -19.17% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 61.93% vs -133.54% in Dec 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
2,133.10
2,137.64
-0.21%
Operating Profit (PBDIT) excl Other Income
60.32
149.89
-59.76%
Interest
119.53
115.44
3.54%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-115.29
-7.37
-1,464.31%
Operating Profit Margin (Excl OI)
2.83%
7.01%
-4.18%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -0.21% vs 7.74% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -1,464.31% vs 80.56% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
2,968.24
3,195.19
-7.10%
Operating Profit (PBDIT) excl Other Income
3.57
181.94
-98.04%
Interest
177.77
174.22
2.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-234.49
-56.19
-317.32%
Operating Profit Margin (Excl OI)
0.12%
5.69%
-5.57%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -7.10% vs 11.24% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -317.32% vs 55.86% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
4,223.79
4,346.07
-2.81%
Operating Profit (PBDIT) excl Other Income
197.91
218.67
-9.49%
Interest
235.39
235.88
-0.21%
Exceptional Items
-149.92
0.00
Consolidate Net Profit
-279.87
-110.36
-153.60%
Operating Profit Margin (Excl OI)
4.69%
5.03%
-0.34%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -2.81% vs 10.78% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -153.60% vs 30.34% in Mar 2025

stock-summaryCompany CV
About Chemplast Sanmar Ltd stock-summary
stock-summary
Chemplast Sanmar Ltd
Small Cap
Commodity Chemicals
Chemplast Sanmar Limited, formerly known as Chemicals & Plastics India Limited, incorporated in 1985. The Company was initially promoted as 'Urethanes India' a subsidiary of Chemplast, the flagship company of the Sanmar Group, Tamil Nadu. Later, it became a fully-owned subsidiary of Chemplast in 1991 when Chemicals & Plastics India Limited was changed to 'Chemplast Sanmar Limited' on September 28, 1995.
Company Coordinates stock-summary
Company Details
9 Cathedral Road , Chennai Tamil Nadu : 600086
stock-summary
Tel: +91-44-28128500
stock-summary
grd@sanmargroup.com
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai